Evidence map›Paper›PMID 25587131›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.

Christoph M Griessinger, Andreas Maurer, Christian Kesenheimer, Rainer Kehlbach, Gerald Reischl, Walter Ehrlichmann, Daniel Bukala, Maren Harant, Funda Cay, Jürgen Brück and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. MIB guides: [Molecular imaging and biology · 2025
    Article
  3. Efficient radiolabeling of mesoporous silica nanoparticles for single-cell PET imaging.European journal of nuclear medicine and molecular imaging · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Theranostics · 2023
    Article
  9. Review
  10. Direct Cell Radiolabeling forChemical reviews · 2022
    Review
  11. Review
  12. Review
  13. Molecular imaging · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Molecular therapy oncolytics · 2021
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Christoph M GriessingerDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Andreas MaurerDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Christian KesenheimerDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Rainer KehlbachDepartment of Diagnostic and Interventional Radiology.
Gerald ReischlDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Walter EhrlichmannDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Daniel BukalaDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Maren HarantDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Funda CayDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center.
Jürgen BrückDepartment of Dermatology.
Renate NordinDepartment of Dermatology.
Ursula KohlhoferDepartment for Pathology, and.
Hans-Georg RammenseeDepartment of Immunology, Eberhard Karls University, 72076 Tübingen, Germany; and German Cancer Consortium, German Cancer Research Center Partner Site Tübingen, 72076 Tübingen, Germany.
Leticia Quintanilla-MartinezDepartment for Pathology, and.
Martin SchallerDepartment of Dermatology.
Martin RöckenDepartment of Dermatology.
Bernd J PichlerDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Bernd.Pichler@med.uni-tuebingen.de.
Manfred KneillingDepartment of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Department of Dermatology.
Siemens (Germany) · DEImaging Center · USGerman Cancer Research Center · DESociety of Interventional Radiology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cells are key players in inflammation, autoimmune diseases, and immunotherapy. Thus, holistic and noninvasive in vivo characterizations of the temporal distribution and homing dynamics of lymphocytes in mammals are of special interest. Herein, we show that PET-based T-cell labeling facilitates quantitative, highly sensitive, and holistic monitoring of T-cell homing patterns in vivo. We developed a new T-cell receptor (TCR)-specific labeling approach for the intracellular labeling of mouse T cells. We found that continuous TCR plasma membrane turnover and the endocytosis of the specific (64)Cu-monoclonal antibody (mAb)-TCR complex enables a stable labeling of T cells. The TCR-mAb complex was internalized within 24 h, whereas antigen recognition was not impaired. Harmful effects of the label on the viability, DNA-damage and apoptosis-necrosis induction, could be minimized while yielding a high contrast in in vivo PET images. We were able to follow and quantify the specific homing of systemically applied (64)Cu-labeled chicken ovalbumin (cOVA)-TCR transgenic T cells into the pulmonary and perithymic lymph nodes (LNs) of mice with cOVA-induced airway delayed-type hypersensitivity reaction (DTHR) but not into pulmonary and perithymic LNs of naïve control mice or mice diseased from turkey or pheasant OVA-induced DTHR. Our protocol provides consequent advancements in the detection of small accumulations of immune cells in single LNs and specific homing to the sites of inflammation by PET using the internalization of TCR-specific mAbs as a specific label of T cells. Thus, our labeling approach is applicable to other cells with constant membrane receptor turnover.

Indexed as

AnimalsAntibodies, MonoclonalApoptosisCopper RadioisotopesDNA DamageMicePositron-Emission TomographyRadioactive TracersRadiographyReceptors, AntigenT-LymphocytesAntibodies, MonoclonalCopper RadioisotopesRadioactive TracersReceptors, Antigenairway DTHRantibody-based cell labelingin vivo cell trackingmouse T cellsPET imaging

Identifiers

PMID25587131
PMCPMC4313850
OpenAlexW2064724925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.